EUS-FNB with or without on-site evaluation for the diagnosis of solid pancreatic lesions (FROSENOR): Protocol for a multicenter randomized non-inferiority trial.
(2019) Digestive and Liver Disease — Vol. 51, n° 6, p. 901-906 (2019)
Files
2019_Crino_Dig_Liver_Dis_Abstract.pdf
Open Access - Adobe PDF
- 178.83 KB
2019_Crino_Dig_Liver_Dis.pdf
Restricted Access - Adobe PDF
- 0 B
Details
- Authors
- Abstract
- BACKGROUND: Rapid on-site evaluation (ROSE) of cytological specimensacquired with EUS-guided fine needle aspiration (EUS-FNA) represents the most accurate available technique to reach a definitive diagnosis in patients with pancreatic solid masses. Recently, needles with high histological yield have been developed for EUS-guided fine needle biopsy (EUS-FNB), with which the need for ROSE can be potentially overcome. AIMS: The primary aim is to compare the diagnostic accuracy of EUS-FNB with or without ROSE. The main endpoint will be measured against the gold standard diagnosis (surgical pathology whenever available or diagnostic work-up in agreement with a clinical course of at least six months). Secondary endpoints include: (a) safety; (b) presence of tissue core; (c) quality of specimens; (d) time of the sampling procedure. Reliability of macroscopic on-site evaluation (MOSE) by endosonographers will be also assessed. METHODS: FROSENOR is an international randomized non-inferiority ongoing study at sixteen centers in four continents. Eight hundred patients will be randomized in two arms (EUS-FNB + ROSE vs. EUS-FNB alone) and outcomes compared. Sample size has been calculated in order to demonstrate the non-inferiority of FNB alone. Randomization and data collection will be performed online. DISCUSSION: This study will ascertain if ROSE is still needed when performing EUS-FNB of solid pancreatic lesions.
- Affiliations
Citations
Crinò, S. F., Manfrin, E., Scarpa, A., Baldaque-Silva, F., Carrara, S., De Nucci, G., Di Mitri, R., Ginés, A., Iglesias-Garcia, J., Itoi, T., Kitano, M., Nguyen, N. Q., Deprez, P., Poley, J.-W., Shami, V. M., Tarantino, I., & Larghi, A. (2019). EUS-FNB with or without on-site evaluation for the diagnosis of solid pancreatic lesions (FROSENOR): Protocol for a multicenter randomized non-inferiority trial. Digestive and Liver Disease, 51(6), 901-906. https://doi.org/10.1016/j.dld.2019.03.008 (Original work published 2019)